Older patients with asthma with elevation of IL-1β, IL-6, and MIP-3a/CCL20 levels were reported to have a greater risk of hospitalization, along with those with IL-6- and IL-23-deteriorated asthma control [93]. This evidence concerns the gene CCL20 and asthma.